Transcription of Five-dose multiple assay with completely …
{{id}} {{{paragraph}}}
Europ. Pharm., 5th Ed. (2005), Ch. , - Five-dose multiple assay with completely randomised design - An in-vitroassay of three hepatitis B vaccines against a standardPage 1 of 7 Document-22 (PLA Customer Support)DOCUMENT-2283D38D90-634B-4DC2-AC 0B-15697A1768D2 Report generated: 12:09:31 PLA (build 623) is a product of Stegmann Systems, Germany Pharm., 5th Ed. (2005), Ch. , - Five-dose multipleassay with completely randomised design - An in-vitro assay ofthree hepatitis B vaccines against a standardDocument-Id:Document-22 (Revision:2)Document Type:Quantitative Response assay /14 Last 12:09:16 Database:PLA Customer SupportDatabase GUID:83d38d90-634b-4dc2-ac0b-15697a1768d 2 CalculationCalculation 12:09:16, Matthias Schmitt (PLA Build 623, nbmsc03, 10014)Report 12:09:31, Matthias Schmitt (PLA Build 623, nbmsc03, 10014)CommentsComment by Matthias Schmitt: ( 12:16:18)European Pharmacopoeia, 5th Edition (2005), Chapter Five-dose multiple assay with completely randomised design - An in-vitro assay of three hepatitis B vaccines against a standardRemarks: Multiplex analysisSignaturesResponsibilityApproval ReviewEurop.
Europ. Pharm., 5th Ed. (2005), Ch. 5.3, 5.1.4.a - Five-dose multiple assay with completely randomised design - An in-vitro assay of three hepatitis B …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}